Loading…
Pall Corporation is investing $114 million to expand production capacity at six existing facilities in Europe and the US, and build a new manufacturing facility in the US, focusing on single-use technology for biopharmaceuticals. The expansion is expected to add over 1,100 jobs globally through end of 2021.
“Pall’s global capacity expansion will ensure our critical products are manufactured and delivered to our customers so people around the world have access to lifesaving vaccines and genes therapies.”pall.com
Summarized from public sources; check the original articles before acting on it.